NCT05094401View on ClinicalTrials.gov

Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes

PHASE3TerminatedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Type2 Diabetes
Interventions
DEVICE

BT-001

BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control.

Trial Locations (1)

75024

Catalyst Health Network, Plano

Sponsors
All Listed Sponsors
collaborator

Catalyst Health Network

UNKNOWN

lead

Better Therapeutics

INDUSTRY